Pre-existing cardiovascular diseases in large b-cell lymphoma

Clicks: 2
ID: 323422
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #237 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Chronic inflammation is central to both cardiovascular disease (CVD) and large B-cell lymphoma (LBCL), yet whether CVD precedes and contributes to LBCL risk—or merely co-occurs due to age and healthcare contact—remains unclear. Objectives To examine the association between pre-diagnosis CVD and subsequent risk of LBCL, with particular attention to temporality and age-specific effects. Methods Using nationwide Swedish registry data (2000–2021), we conducted a matched case–control study including 11,258 patients with LBCL and 112,218 population controls. CVD occurring within 10 years prior to diagnosis was ascertained from inpatient, outpatient, and prescription registries; a 3-month lag period was applied to reduce reverse causation; sensitivity analyses used alternative lag periods (0 and 12 months). Conditional logistic regression adjusted for sociodemographic factors and comorbidities was performed in the overall study population, with prespecified analyses stratified by age at diagnosis (≤65 vs >65 years). Results Overall, prior CVD was not associated with LBCL risk (OR 1.03, 95% CI 0.98–1.08). However, age-related heterogeneity was observed in the primary lagged analysis: among individuals diagnosed at ≤65 years, prior CVD was associated with increased LBCL risk (OR 1.15, 95% CI 1.06–1.25), whereas no association was seen in older individuals (OR 0.98, 95% CI 0.93–1.03; P for interaction <0.001). The age-specific association was driven by arterial hypertension, the only CVD subtype consistently associated with increased risk in younger patients. Findings were consistent in sensitivity analyses using alternative lag periods (0 and 12 months). Conclusion In this population-based analysis, we found no evidence of a broad association between pre-existing CVD and LBCL risk after accounting for diagnostic timing. Nonetheless, the age-specific signal observed among individuals diagnosed at ≤65 years—driven primarily by arterial hypertension—suggests meaningful heterogeneity in the CVD–LBCL association across the lifespan. These findings underscore the importance of temporality and age context in reverse cardio-oncology research.
Reference Key
openalex_W7172251464 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors T M Nicolaescu, K D Abalo, C Morth, I Glimelius, J Sundstrom, C Smedby, G Enblad
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.081
URL
https://doi.org/10.1093/eurheartjsupp/suag097.081
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.